AIMS: The aim of this study was to investigate the prognostic impact of right ventricular (RV) size in patients with chronic heart failure. METHODS AND RESULTS: Normal volunteers (n = 80) and patients (n = 380) with left ventricular (LV) ejection fraction <45% on echocardiography and on optimal treatment for heart failure underwent cardiac magnetic resonance imaging with measurement of LV and RV volumes, mass and ejection fraction. The mean and the standard deviation (SD) of the RV end-systolic volume index in normal subjects were used to define the normal range as: mean RV end-systolic volume index +2 SD. Patients with dilated RV (>2 SD beyond the mean) (25%) had more frequent evidence of fluid overload in clinical examination and greater LV dimensions (P < 0.0001). During follow-up (median 45, interquartile range: 28-66 months), 37% of patients with and 24% without RV dilation died (log-rank test = 8.4; P = 0.004). In a multivariable Cox regression model, including 13 other clinical variables, RV (HR: 1.08/10 mL/m(2), 95% CI: 1.00-1.18, P = 0.044), but not LV, end-systolic volume index predicted a worse outcome. CONCLUSION: Twenty-five per cent of patients with heart failure due to LV systolic dysfunction have a dilated right ventricle. Greater RV dimensions predict mortality in patients with chronic heart failure. Treatments aimed at preserving or enhancing RV structure and function, possibly by unloading the RV by reducing pulmonary vascular resistance or left atrial pressure, should be investigated.
AIMS: The aim of this study was to investigate the prognostic impact of right ventricular (RV) size in patients with chronic heart failure. METHODS AND RESULTS: Normal volunteers (n = 80) and patients (n = 380) with left ventricular (LV) ejection fraction <45% on echocardiography and on optimal treatment for heart failure underwent cardiac magnetic resonance imaging with measurement of LV and RV volumes, mass and ejection fraction. The mean and the standard deviation (SD) of the RV end-systolic volume index in normal subjects were used to define the normal range as: mean RV end-systolic volume index +2 SD. Patients with dilated RV (>2 SD beyond the mean) (25%) had more frequent evidence of fluid overload in clinical examination and greater LV dimensions (P < 0.0001). During follow-up (median 45, interquartile range: 28-66 months), 37% of patients with and 24% without RV dilation died (log-rank test = 8.4; P = 0.004). In a multivariable Cox regression model, including 13 other clinical variables, RV (HR: 1.08/10 mL/m(2), 95% CI: 1.00-1.18, P = 0.044), but not LV, end-systolic volume index predicted a worse outcome. CONCLUSION: Twenty-five per cent of patients with heart failure due to LV systolic dysfunction have a dilated right ventricle. Greater RV dimensions predict mortality in patients with chronic heart failure. Treatments aimed at preserving or enhancing RV structure and function, possibly by unloading the RV by reducing pulmonary vascular resistance or left atrial pressure, should be investigated.
Authors: Neal A Chatterjee; Ravi V Shah; Venkatesh L Murthy; Amy Praestgaard; Sanjiv J Shah; Corey E Ventetuolo; R Graham Barr; Richard Kronmal; Joao A C Lima; David A Bluemke; Michael Jerosch-Herold; Alvaro Alonso; Steven M Kawut Journal: Circ Arrhythm Electrophysiol Date: 2017-01
Authors: Pierpaolo Pellicori; Anil C Joseph; Jufen Zhang; Elena Lukaschuk; Nasser Sherwi; Christos V Bourantas; Huan Loh; Andrew L Clark; John Gf Cleland Journal: Clin Res Cardiol Date: 2015-04-23 Impact factor: 5.460
Authors: Steven M Kawut; R Graham Barr; João A C Lima; Amy Praestgaard; W Craig Johnson; Harjit Chahal; Kofo O Ogunyankin; Michael R Bristow; Jorge R Kizer; Harikrishna Tandri; David A Bluemke Journal: Circulation Date: 2012-08-29 Impact factor: 29.690
Authors: Justin L Grodin; Mark H Drazner; Matthias Dupont; Wilfried Mullens; David O Taylor; Randall C Starling; W H Wilson Tang Journal: Am Heart J Date: 2015-02-28 Impact factor: 4.749
Authors: Geoffrey C Colin; Bernhard L Gerber; Christophe de Meester de Ravenstein; David Byl; Anna Dietz; Michele Kamga; Agnes Pasquet; David Vancraeynest; Jean-Louis Vanoverschelde; Anne-Marie D'Hondt; Benoit Ghaye; Anne-Catherine Pouleur Journal: Eur Radiol Date: 2018-05-14 Impact factor: 5.315
Authors: Andrew J Swift; Dave Capener; Chris Johns; Neil Hamilton; Alex Rothman; Charlie Elliot; Robin Condliffe; Athanasios Charalampopoulos; Smitha Rajaram; Allan Lawrie; Michael J Campbell; Jim M Wild; David G Kiely Journal: Am J Respir Crit Care Med Date: 2017-07-15 Impact factor: 21.405